BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21644844)

  • 21. The pharmacologic rationale for the clinical use of antidepressants.
    Pinder RM
    J Clin Psychiatry; 1997 Nov; 58(11):501-8. PubMed ID: 9413422
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological justification for the use of new antidepressant drugs].
    Nowakowska E; Kus K; Bobkiewicz-Kozłowska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mirtazapine: other indications.
    Falkai P
    J Clin Psychiatry; 1999; 60 Suppl 17():36-40; discussion 46-8. PubMed ID: 10446741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirtazapine: clinical advantages in the treatment of depression.
    Burrows GD; Kremer CM
    J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():34S-39S. PubMed ID: 9090576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS.
    Chopra A; Pendergrass DS; Bostwick JM
    Psychosomatics; 2011; 52(1):92-4. PubMed ID: 21300203
    [No Abstract]   [Full Text] [Related]  

  • 26. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mirtazapine: not a dual action antidepressant?
    Gillman PK
    Aust N Z J Psychiatry; 2004 Apr; 38(4):266-7. PubMed ID: 15038808
    [No Abstract]   [Full Text] [Related]  

  • 28. Mirtazapine for alcohol dependence: a case report.
    Crockford DN; White WD
    J Clin Psychiatry; 2005 Apr; 66(4):540. PubMed ID: 15816801
    [No Abstract]   [Full Text] [Related]  

  • 29. New onset multimodal hallucinations associated with mirtazapine: a case report.
    Padala KP; Padala PR; Malloy T; Burke WJ
    Int Psychogeriatr; 2010 Aug; 22(5):837-9. PubMed ID: 20500925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migraine headache prophylaxis and treatment with low-dose mirtazapine.
    Lévy E; Margolese HC
    Int Clin Psychopharmacol; 2003 Sep; 18(5):301-3. PubMed ID: 12920393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mirtazapine in pregnancy and lactation: data from a case series.
    Smit M; Wennink H; Heres M; Dolman KM; Honig A
    J Clin Psychopharmacol; 2015 Apr; 35(2):163-7. PubMed ID: 25689290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mirtazapine associated with recurrent pancreatitis - a case report.
    Hussain A; Burke J
    J Psychopharmacol; 2008 May; 22(3):336-7. PubMed ID: 18208920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High mirtazapine plasma levels in infant after breast feeding: case report and review of the literature.
    Tonn P; Reuter SC; Hiemke C; Dahmen N
    J Clin Psychopharmacol; 2009 Apr; 29(2):191-2. PubMed ID: 19512989
    [No Abstract]   [Full Text] [Related]  

  • 38. Mirtazapene: a noradrenergic and specific serotonergic antidepressant.
    Gray R
    Ment Health Care; 1998 Mar; 1(7):233-4. PubMed ID: 9791425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depressed in-patients respond differently to imipramine and mirtazapine.
    Bruijn JA; Moleman P; Mulder PG; van den Broek WW
    Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitrazapine-associated palinopsia.
    Ihde-Scholl T; Jefferson JW
    J Clin Psychiatry; 2001 May; 62(5):373. PubMed ID: 11411821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.